| WT sham | KO sham | KD sham | WT CLP | KO CLP | KD CLP |
---|---|---|---|---|---|---|
Systemic response | Â | Â | Â | Â | Â | Â |
   MIP-2 concentration (pg/ml in plasma × 104) | 0 ± 0 | 0 ± 0 | 0 ± 0 | 13 ± 5** | 2 ± 1* | 2 ± 1* |
   IL-6 concentration (pg/ml in plasma × 103) | 0 ± 0 | 0 ± 0 | 0 ± 0 | 18 ± 5* | 19 ± 10* | 22 ± 8* |
Lung injury | Â | Â | Â | Â | Â | Â |
   Pathology score | 1.67 ± 0.42 | 1.8 ± 0.49 | 1.71 ± 0.42 | 4.17 ± 0.31* | 2.00 ± 0.63 | 2.00 ± 0.45 |
   Permeability (protein in BAL (μg/ml)) | 194 ± 7 | 199 ± 3 | 195 ± 8 | 234 ± 13* | 191 ± 13 | 192 ± 10 |
   Neutrophil infiltration (cell × 103/ml BAL) | 0.3 ± 0.2 | 0.8 ± 0.4 | 0.2 ± 0.2 | 11.7 ± 5.9* | 0.2 ± 0.1 | 0.8 ± 0.3 |
   MIP-2 concentration (pg/ml in BAL × 102) | 0 ± 0 | 0 ± 0 | 0 ± 0 | 21.6 ± 1.0* | 1.1 ± 0.4 | 1.2 ± 0.5 |
   IL-6 concentration (pg/ml in BAL × 102) | 0 ± 0 | 0 ± 0 | 0 ± 0 | 14 ± 5* | 1 ± 0 | 2 ± 0 |
   Apoptosis (% apoptotic cells) | 0.3 ± 0.1 | 1.2 ± 0.2* | 1.0 ± 0.2* | 7.7 ± 0.8** | 1.3 ± 0.3* | 1.2 ± 0.3* |
   Akt phosphorylation (fold increase over WT sham) | 1.0 ± 0.1 | 0.7 ± 0.0* | 0.7 ± 0.1* | 1.4 ± 0.1** | 0.8 ± 0.1* | 0.8 ± 0.1* |
Liver injury | Â | Â | Â | Â | Â | Â |
   Pathology score | 0.33 ± 0.21 | 0.20 ± 0.20 | 0.20 ± 0.20 | 2.83 ± 0.17** | 1.20 ± 0.37* | 1.83 ± 0.17* |
   Apoptosis (% apoptotic cells) | 1.0 ± 0.2 | 4.6 ± 1.2* | 4.3 ± 1.0* | 23.9 ± 2.7** | 5.6 ± 0.7* | 4.9 ± 1.0* |
Coagulation | Â | Â | Â | Â | Â | Â |
   tPA (pg/ng protein) | 404 ± 17 | 369 ± 53 | 423 ± 23 | 1 ± 1** | 104 ± 36* | 61 ± 31* |
   PAI-1 (pg/μg protein) | 2.9 ± 0.2 | 2.7 ± 0.2 | 3.1 ± 0.4 | 84.8 ± 13.4** | 50.5 ± 9.2* | 52.0 ± 9.0* |
   Fibrinogen (ng/mg protein) | 805 ± 35 | 807 ± 40 | 779 ± 33 | 1424 ± 89** | 1043 ± 57* | 1079 ± 58* |